NCT00303069View on ClinicalTrials.gov

V710 First-In-Man (FIM) Study (V710-001)

PHASE1CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Staphylococcal Infections
Interventions
BIOLOGICAL

V710

Single dose of V710 (at dosages of 5 μg, 30 μg, or 90 μg) intramuscularly

BIOLOGICAL

Comparator: Placebo

Single dose of saline placebo intramuscularly

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00303069 - V710 First-In-Man (FIM) Study (V710-001) | Biotech Hunter | Biotech Hunter